BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9062957)

  • 1. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children.
    Ries M; Klinge J; Rauch R
    Thromb Res; 1997 Feb; 85(4):341-4. PubMed ID: 9062957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostasis in newborns of smoking and nonsmoking mothers.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the activation markers of blood coagulation and fibrinolysis in the neonatal period].
    Ries M; Klinge J; Rauch R; Zenker M; Aydin I; Harms D
    Klin Padiatr; 1996; 208(6):350-4. PubMed ID: 9064377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.
    Saatvedt K; Lindberg H; Michelsen S; Pedersen T; Geiran OR
    Scand J Clin Lab Invest; 1995 Jul; 55(4):359-67. PubMed ID: 7569739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome.
    Kodama H; Fukuda J; Karube H; Matsui T; Shimizu Y; Tanaka T
    Fertil Steril; 1996 Sep; 66(3):417-24. PubMed ID: 8751741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates.
    Aronis S; Platokouki H; Photopoulos S; Adamtziki E; Xanthou M
    Biol Neonate; 1998 Nov; 74(5):337-44. PubMed ID: 9742262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
    Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 11. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.
    Flom-Halvorsen HI; Ovrum E; Tangen G; Brosstad F; Ringdal MA; Oystese R
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):610-7. PubMed ID: 10504624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
    Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
    Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
    Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
    Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis.
    Speiser W; Pabinger-Fasching I; Kyrle PA; Kapiotis S; Kottas-Heldenberg A; Bettelheim P; Lechner K
    Blut; 1990 Nov; 61(5):298-302. PubMed ID: 2271776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
    Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.